U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 125360
Company: MERZ PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
Xeomin incobotulinumtoxinA 50 UNITS/VIAL INJECTABLE;INJECTION Prescription None No No
Xeomin incobotulinumtoxinA 100 UNITS/VIAL INJECTABLE;INJECTION Prescription None No No
Xeomin incobotulinumtoxinA 200 UNITS/VIAL INJECTABLE;INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/30/2010 ORIG-1 Approval N/A Label (PDF)
Letter (PDF)
Review
Summary Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/125360s000,s001ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/125360s0000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/125360s000SumR.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/08/2023 SUPPL-97 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125360Orig1s097ltr.pdf
08/13/2021 SUPPL-93 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s093ltr.pdf
12/18/2020 SUPPL-92 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s086s092lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125360Orig1s086, s092ltr.pdf
04/19/2021 SUPPL-91 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
04/19/2021 SUPPL-90 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
04/19/2021 SUPPL-89 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
04/19/2021 SUPPL-88 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
04/19/2021 SUPPL-87 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
12/18/2020 SUPPL-86 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s086s092lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125360Orig1s086, s092ltr.pdf
08/18/2020 SUPPL-78 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s078lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125360Orig1s078ltr.pdf
05/10/2019 SUPPL-74 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125360s074lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125360Orig1s074ltr.pdf
07/03/2018 SUPPL-73 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125360Orig1s073ltr.pdf
12/22/2015 SUPPL-67 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s067lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125360Orig1s067ltr.pdf
11/20/2015 SUPPL-66 Supplement Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s066lbl.pdf
04/11/2013 SUPPL-45 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125360s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125360Orig1s045ltr.pdf
07/16/2012 SUPPL-40 Supplement Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125360Orig1s040ltr.pdf
06/02/2011 SUPPL-12 Supplement

Label is not available on this site.

07/20/2011 SUPPL-7 Supplement Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125360s007lbl.pdf
07/30/2010 SUPPL-1 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/125360s000,s001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/08/2023 SUPPL-97 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf
08/13/2021 SUPPL-93 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf
04/19/2021 SUPPL-91 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
04/19/2021 SUPPL-90 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
04/19/2021 SUPPL-89 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
04/19/2021 SUPPL-88 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
04/19/2021 SUPPL-87 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
12/18/2020 SUPPL-92 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s086s092lbl.pdf
12/18/2020 SUPPL-86 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s086s092lbl.pdf
08/18/2020 SUPPL-78 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s078lbl.pdf
05/10/2019 SUPPL-74 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125360s074lbl.pdf
07/03/2018 SUPPL-73 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf
12/22/2015 SUPPL-67 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s067lbl.pdf
11/20/2015 SUPPL-66 Manufacturing (CMC) Label (PDF) This supplement type does not usually require new labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s066lbl.pdf
04/11/2013 SUPPL-45 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125360s045lbl.pdf
07/20/2011 SUPPL-7 Efficacy Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125360s007lbl.pdf
07/30/2010 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf
07/30/2010 SUPPL-1 Efficacy Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf
Back to Top